Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Innate Pharma S.A. (NASDAQ: IPHA) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Innate Pharma S.A. (NASDAQ: IPHA) concerning whether a series of statements by Innate Pharma S.A. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On January 9, 2020, the Company revealed its decision “to suspend enrollment of new patients” in its TELLOMAK Phase II trial evaluating the efficacy and safety of lacutamab (IPH4102) in patients with advanced T-cell lymphomas. According to Innate “ongoing discussions with regulatory authorities regarding Good Manufacturing Practice (GMP) deficiencies at the Company’s manufacturing subcontractor site that manages the fill and finish operations of the lacutamab clinical vials.”
Following this news, NASDAQ: IPHA fell $0.76 per share, or 9.99%, to close at $6.85 on January 9, 2020.
Based in Marseille, France, and founded in 1999 Innate Pharma S.A. discovers and develops therapeutic antibodies for the treatment of cancer in France and internationally.
If you purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) on or before January 9, 2020, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
